Category: psoriasis

According to a new study, plaque psoriasis patients with Fitzpatrick skin types IV through VI treated with calciprotriene/betamethasone dipropionate (CAL/BDP) cream respond in a similar manner as those with Fitzpatrick skin types I through III.

According to a recent study, patients with moderate-to-severe plaque psoriasis have lower fertility rates and higher risk of pregnancy loss than women without psoriasis.

According to a new study, tildrakizumab is linked to improved quality of life (QoL) and sleep in patients with moderate-to-severe plaque psoriasis.

According to a new study, exposure to biologics during pregnancy and conception does not increase the risk of adverse events in pregnant psoriasis patients.

According to a new study, lower limbs are the hardest to treat with narrowband-UVB therapy on patients with chronic plaque psoriasis.

According to a new study, psoriasis patients being treated with acitretin are at greater risk of developing psychiatric disorders compared to those receiving disease-modifying antirheumatic drugs (DMARDs).

According to a new study, psoriasis patients treated with methotrexate are almost three times more likely to develop nonmelanoma skin cancer when compared to those not on methotrexate.

According to a new study, psoriasis patients reported that application feel, non-staining quality and quick absorption were the most important factors in their preference of topical treatments and in ensuring treatment adherence.

According to a recent study, guselkumab does not increase cancer risk in psoriasis (PsO) patients compared to general and psoriasis populations.

According to a recent press release, risankizumab has been shown to be efficacious and safe in patients with plaque psoriasis who have a suboptimal response to IL-17A inhibitors.